PFE - Pfizer to close Seagen buyout this week as regulatory reviews complete
2023-12-12 07:18:30 ET
More on Pfizer, Seagen, etc.
- Johnson & Johnson Vs. Pfizer: Better Pharma Stock?
- Pfizer: This Year's Disaster Should Set The Stage For A Strong 2024
- Pfizer: Slimming Down After COVID Franchise And Obesity Pipeline Setbacks
- Pfizer's bleeding disorder therapy under review by FDA, EMA
- Seagen lymphoma drug shows 100% progression free survival in Phase 2 trial
For further details see:
Pfizer to close Seagen buyout this week as regulatory reviews complete